Introduction
Histoplasmosis is an infection caused by the fungal organism Histoplasma capsulatum. It usually affects the respiratory system. 1 With the inhalation of fungal spores, H capsulatum infection often has an impact on pulmonary function.
H capsulatum is a saprophytic and dimorphic fungus. Its mycelial form is found in the soil, and its microconidia, or spore, form is found in the excrement of bats, pigeons, and birds. 2 It is most prevalent in the Ohio River and Mississippi River valleys. 2 Some 60 to 90% of those living in endemic areas have been exposed to this fungus. 3 The reported prevalence of histoplasmosis in adults older than 65 years is estimated at 3.4 cases per 100,000 population. 4 Dissemination of H capsulatum is most common in immunocompromised patients. Patients with immunosuppression secondary to a history of organ transplantation, human immunodeficiency virus (HIV) infection, prolonged corticosteroid use, Hodgkin lymphoma, and/ or systemic lupus erythematosus are at risk of dissemination of disease. 5 Manifestations of dissemination include fever, weakness, weight loss, mucocutaneous lesions, and hepatosplenomegaly. 5, 6 Few cases regarding the isolated effects of this fungus in the head and neck have been reported. Some 30 to 50% of patients with disseminated histoplasmosis have oral lesions. [5] [6] [7] Other manifestations in the head and neck have been reported in the larynx. [8] [9] [10] Patients with laryngeal lesions secondary to histoplasmosis can experience hoarseness, dysphagia, and/or dyspnea. 11 However, such presentations are generally found in patients who are severely immunocompromised; rarely have they been noted in immunocompetent patients.
To the best of our knowledge, the literature contains only 1 report of an immunocompetent patient presenting with laryngeal histoplasmosis 12 and only 4 cases of patients with an oral lesion. [13] [14] [15] [16] Considering the rarity of histoplasmosis of the head and neck in immunocompetent patients, the paucity of reports, and the constellation of nonspecific symptoms, few clinicians possess the knowledge needed to make a proper diagnosis. In this article, we describe the cases of 2 immunocompetent patients who presented with a head and neck manifestation of histoplasmosis-one involving the oral cavity and the other the larynx. In presenting these rare cases, we aim to provide clinicians with an opportunity to learn more about the presentation of this disease so that they can properly diagnose and treat their patients.
Case reports Patient 1. An 80-year-old man was referred for evaluation of oral cavity lesions. He had developed a lesion on the dorsum of his tongue 6 months earlier, and this was followed by the development of a lesion on the floor of the mouth 1 month before presentation. The lesions were painful to palpation. The patient had also experienced a 10-lb weight loss during this time.
The man's medical history was positive for smoking 3 or 4 cigarettes per day, but he had quit smoking 30 years earlier. He also had developed herpes zoster on his parietal scalp 2 years earlier. His primary care physician had prescribed nystatin swish-and-spit, but it failed to resolve his lesions and symptoms.
On examination, a deep, fissured, 2-cm ulceration was observed at midline of the dorsal tongue. It featured smooth, rolled borders and minimal erythema (figure 1). The lesion was tender to palpation. There was no exudate, bleeding, or surrounding vesicular lesions. An accompanying 1.5-cm lesion was found at the midline floor of the mouth. This lesion exhibited rounded, smooth, rolled borders. Several nearby granuloma-like papules surrounded this lesion.
The biopsy sample was reported by the evaluating pathologist as a severe, diffuse, chronic granulomatous inflammation associated with histoplasmosis. The specimen was found to contain small microorganisms consistent with H capsulatum. Periodic acid-Schiff (PAS) and Gomori methenamine silver (GMS) stains were strongly positive. The patient was treated with oral itraconazole, and his oral lesions resolved.
Patient 2. A 57-year-old man presented with a 6-month history of sore throat. Associated with this sore throat were symptoms of odynophagia, bilateral referred otalgia, hoarseness, increased mucus production, and a 45-to 50-lb weight loss during this same period. His primary care physician had attempted to treat him with courses of amoxicillin and steroids, but the patient's symptoms remained unchanged. The patient had a 15-pack-year smoking history, as well as a history of travel to Peru and ownership of a parrot.
Upper endoscopy revealed reflux changes and a hiatal hernia. A barium swallow study revealed mild aspiration. Based on these findings, the patient was prescribed 40 mg/day of esomeprazole, but again his symptoms failed to resolve.
On examination, the patient was found to have a breathy, strained voice. No neck mass or lymphadenopathy was found. Videostroboscopy identified a diffuse erythema of the larynx (figure 2). His vocal fold mobility was intact bilaterally. Computed tomography of the neck demonstrated diffuse laryngeal edema without a focal mass or lymphadenopathy. Laryngeal electromyography detected a 20% decrease in recruitment of both superior laryngeal nerves, as well as fibrillation potentials of the right cricothyroid muscle.
The patient underwent direct laryngoscopy with biopsy. The pathologist reported the specimen as a caseating granuloma with ulceration, most consistent with H capsulatum. The patient was evaluated by an infectious disease specialist and started on oral ketoconazole. His symptoms resolved, and he recovered well.
Discussion
Humans are most often exposed to H capsulatum when the fungal spores become aerosolized, which allows the airborne spores (microconidia) to be drawn into the respiratory system through inspiration. 13 In immunocompromised patients, the immune system is often unable to remove these microconidia, and this can result in the germination of spores and subsequent pneumonitis. This process may progress to dissemina- tion to other organ systems, including the central nervous system, gastrointestinal tract, and lymph nodes. 17 In patients with histoplasmosis, identification of the fungal species can be made through tissue or culture analysis. Histopathology will demonstrate chronic, noncaseating granulomatous inflammation, often with numerous microorganisms that measure 1 to 2 μm in diameter and are surrounded by a clear halo. They also may be seen within macrophages or giant cells. Special stains, including PAS and GMS, are used to confirm the identity of the microorganism. 13 Serum antigen testing, which is usually used as a means of diagnosing more common pulmonary infections, also can be performed for the diagnosis of histoplasmosis. However, although this test provides rapid results, it carries a 17% false-negative rate. 18 Antibody testing via enzyme immunoassay also has been reported, as measurements of IgM and IgG classes of antibodies are used to detect infection. 18 Combined antigen and antibody testing has been reported to have a sensitivity of 96.3%; however, this combination has not been formally tested in head and neck infections alone. 18 Although dissemination of H capsulatum to extrapulmonary sites can occur, it is quite rare in immunocompetent patients. Immunocompetent patients often fight off infection with phagocytic cells, including macrophages and multinucleated giant cells. In rare cases, including those described in this article, H capsulatum may still infect sites within the aerodigestive tract, such as the oral cavity and larynx.
Most reports of oral cavity histoplasmosis have described nodular, plaque-like, and vegetative lesions. 2, 13, 14 The etiology of such lesions can be confused with benign causes, such as traumatic or aphthous ulcers. Other infectious causes (e.g., paracoccidioidomycosis) and invasive fungal infections (e.g., mucormycosis and aspergillosis) are among other possibilities. Malignancies, such as squamous cell carcinoma and NK/T-cell lymphoma, are diagnoses of concern, as well. 13, 14, 19 Laryngeal manifestations of histoplasmosis have presented in a variety of ways, including irregular, thickened, and/or edematous vocal folds, as well as focal areas of solitary ulcerated or necrotic nodules. 1, 20 Other conditions manifest with similar symptoms. Common mimickers of laryngeal histoplasmosis range from squamous cell carcinoma to tuberculosis, thereby making a thorough workup complete with histologic analysis essential to making the correct diagnosis. 4 For both oral cavity and laryngeal histoplasmosis, the importance of history taking, clinical examination, and a proper workup are essential to treatment. It is necessary to rule out causes of immunocompromised conditions, such as HIV infection and malignancies. Both of our patients were determined to be immunocompetent on the basis of their clinical history and physical examination. They did not have any history of immune disease (e.g., HIV infection), chemotherapy treatments, or chronic corticosteroid use. Once such etiologies have been ruled out, clinicians can then pursue the treatment of patients with histoplasmosis isolated to these sites in the head and neck.
Treatment is often initiated with an oral conazole for 3 to 4 weeks. 21 Oral conazole options have been found to be quite successful. Oral itraconazole has been reported to effectively treat histoplasmosis of the head and neck in 85 to 100% of patients. 22 Oral fluconazole has been found to be effective in 86% of patients, and oral ketoconazole in 56 to 70% of patients. 22 Other reported treatment options include topical nystatin for 3 weeks followed by an oral conazole if topical treatment is unsuccessful. 21 Application of gentian violet to the fungal lesion also has been reported; however, the carcinogenic potential of gentian violet makes this option less favored. 21 If first-line treatment with an oral conazole fails, refractory cases may be treated with intravenous amphotericin B, as can those cases marked by significant tissue invasion. 21 In conclusion, although histoplasmosis is an uncommon diagnosis in the otolaryngology clinic, it should remain a consideration in the differential diagnosis of lesions within the aerodigestive tract, including the oral cavity and larynx. Since it is an uncommon diagnosis as well as a mimicker of more common disorders of the head and neck, histoplasmosis is frequently overlooked. Early diagnosis with biopsy can prompt effective treatment, resulting in a markedly improved quality of life for the patient. It is important for clinicians to maintain a high index of suspicion to achieve the best outcomes for patients with histoplasmosis.
